A Report of Two Cases of Solid Facial Edema in Acne by Kuhn-Régnier, Sarah et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
A Report of Two Cases of Solid Facial Edema in Acne
Kuhn-Régnier, Sarah; Mangana, Joanna; Kerl, Katrin; Kamarachev, Jivko; French, Lars E; Cozzio,
Antonio; Navarini, Alexander A
DOI: https://doi.org/10.1007/s13555-017-0173-6
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-140322
Published Version
Originally published at:
Kuhn-Régnier, Sarah; Mangana, Joanna; Kerl, Katrin; Kamarachev, Jivko; French, Lars E; Cozzio, An-
tonio; Navarini, Alexander A (2017). A Report of Two Cases of Solid Facial Edema in Acne. Dermatology
and Therapy, 7(1):167-174.
DOI: https://doi.org/10.1007/s13555-017-0173-6
CASE REPORT
A Report of Two Cases of Solid Facial Edema in Acne
Sarah Kuhn-Re´gnier . Joanna Mangana . Katrin Kerl .
Jivko Kamarachev . Lars E. French . Antonio Cozzio . Alexander A. Navarini
Received: July 12, 2016 / Published online: February 6, 2017
 The Author(s) 2017. This article is published with open access at Springerlink.com
ABSTRACT
Introduction: Solid facial edema (SFE) is a rare
complication of acne vulgaris. To examine the
clinical features of acne patients with solid
facial edema, and to give an overview on the
outcome of previous topical and systemic
treatments in the cases so far published.
Methods: We report two cases from Switzer-
land, both young men with initially papulo-
pustular acne resistant to topical retinoids.
Results: Both cases responded to oral iso-
tretinoin, in one case combined with oral ster-
oids. Our cases show a strikingly similar clinical
appearance to the cases described by Connelly
and Winkelmann in 1985 (Connelly MG,
Winkelmann RK. Solid facial edema as a com-
plication of acne vulgaris. Arch Dermatol.
1985;121(1):87), as well as to cases of
Morbihan’s disease that occurs as a rare com-
plication of rosacea.
Conclusion: Even 30 years after, the cause of
the edema remains unknown. In two of the
original four cases, a potential triggering factor
was identified such as facial trauma or insect
bites; however, our two patients did not report
such occurrencies. The rare cases of solid facial
edema in both acne and rosacea might hold the
key to understanding the specific inflammatory
pattern that creates both persisting inflamma-
tion and disturbed fluid homeostasis which can
occur as a slightly different presentation in
dermatomyositis, angioedema, Heerfordt’s syn-
drome and other conditions.
Keywords: Adrenergic receptors; Brimonidine;
Erythema; Rosacea; Vasoconstriction;
Worsening of erythema
INTRODUCTION
Acne vulgaris is a disorder of the pilosebaceous
unit, namely the sebaceous gland and the hair
follicle it is attached to. Some 85% of people
have acne at some point in their life, especially
during puberty [1], and therefore it could be
considered the most common inflammatory
skin disease. Due to disfiguration and scarring,
the disease has major effects on the patient’s
quality of life [2], eliciting depression, social
Enhanced content To view enhanced content for this
article go to http://www.medengine.com/Redeem/
B687F0603931CB7A.
S. Kuhn-Re´gnier
University of Zurich, Zurich, Switzerland
J. Mangana  K. Kerl  J. Kamarachev 
L. E. French  A. A. Navarini (&)
Department of Dermatology, University Hospital
Zurich, Zurich, Switzerland
e-mail: alexander.navarini@usz.ch
A. Cozzio
Department of Dermatology, Cantonal Hospital of
St. Gallen, St. Gallen, Switzerland
Dermatol Ther (Heidelb) (2017) 7:167–174
DOI 10.1007/s13555-017-0173-6
withdrawal, anxiety and a higher rate of
unemployment [3, 4].
The pathogenesis includes several compo-
nents whose interplay is only partially known.
The androgen surge in puberty stimulates the
sebocytes and follicular keratinocytes that pro-
liferate and obstruct the outflow tract of the hair
follicle. This leads to a hyperplasia of the seba-
ceous glands and the seborrhea that is charac-
teristic for acne. Propionibacterium acnes, an
opportunistic grampositive anaerobic strain
found in the seborrheic areas of the skin, breaks
down fatty acids. These compounds are believed
to elicit inflammation and chemotaxis of neu-
trophil granulocytes and adaptive immune cells
to the follicular epithelium. This ends in the
rupture and release of sebum, microorganisms
and keratin into the dermis. Accumulation of
neutrophils, lymphocytes and foreign-body
giant cells leads to the characteristic erythema-
tous papules, pustules, nodules and cysts of
inflammatory acne [1, 5].
In very rare cases, however, the primary acne
lesions occur together with a wooden, solid
facial edema (SFE). Typically, the acne lesions
are moderate to severe but in no way extreme,
hence this phenomenon cannot be explained
by simple edema due to inflammation. It was
first observed and published by Connelly and
Winkelmann in 1985 [6]. Although we believe
we have understood more about acne patho-
genesis since then, solid facial edema remains a
mystery. It has been suggested that chronic
inflammation, comparable to other body
regions such as the legs, damages the lymphatic
system and leads to fibrosis, which is further
supported by mast cells. Accordingly, early
treatment before damage is irreversible seems
sensible. Here, we report two Swiss cases of SFE
in acne vulgaris and summarize the clinical
features and treatment responses of SFE cases in
the literature.
Case Report
A 18-year old carpenter presented with numer-
ous papules and pustules on the forehead and
cheeks compatible with acne. Initially, he had
been fruitlessly treated with topical retinoids.
Instead, after 6 months of therapy, the patient
developed a localized, symmetric, wooden,
non-pitting edema over the cheeks and
infraorbital regions, the lower front and gla-
bella. All edematous areas were beset with
multiple comedones and papulopustules
(Fig. 1). A punch biopsy revealed some dermal
edema and fibrosis as well as moderate infil-
trates composed of lymphocytes and neu-
trophils granulocytes around the pilo-sebaceous
unit (Fig. 2). Treatment with 2 mg/kg oral
prednisone for 12 days in combination with
20 mg isotretinoin for 2 months resulted in a
complete regression of the edema.
The second case was an otherwise healthy
20-year-old student, who consulted for a per-
sisting edematous reaction of the left upper and
lower eyelid and cheek that had developed
5 months earlier. It had started during treat-
ment with topical retinoids for erythematous
papules and pustules interpreted as acne vul-
garis that had arisen on the forehead, cheeks,
chin and pre-sternal area. Shortly after com-
mencing the treatment, the indurated edema
developed. No comedones nor teleangiectasias
were present. A biopsy showed a spongiotic
dermatitis, probably due to local treatment, as
well as acne of a typical mixed cellular and
Fig. 1 Diffuse papules and pustules with facial wooden
edema in the periorbital area
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mixed perifollicular inflammation. Further,
fibrosis in the middle and dermis was quite
prominent. After 8 months treatment with iso-
tretinoin 20 mg per day and an antihistamine,
the facial edema slowly cleared.
Compliance with Ethics Guidelines
Informed consent was obtained from the
patients prior to publication.
DISCUSSION
A total of 20 similar cases have been reported so
far in the medical literature (Table 1). Multiple
strategies were used in attempts to treat the
edema. The first therapy attempt, with elastic
facial stockings for several months as reported
by Connelly and Winkelmann, failed [6]. In 8
cases, 0.5–1 mg/kg per day isotretinoin was
reported as an effective treatment of the facial
edema in acne vulgaris [7–10]. There were two
reported cases of treatment failure after 3 and
4 months of therapy with isotretinoin, which
corresponds with our experience, as in the sec-
ond case, we observed improvement only after
8 months of treatment [11, 12]. Therapy
attempts with oral prednisone alone showed no
improvement of the facial edema, in contrast to
successes by a combination with isotretinoin
[13]. Surgical therapy after failure of
conventional treatment, as reported in one
case, led to complete resolution [14]. It remains
unknown whether the result was aesthetically
satisfying. In the related condition called Mor-
bihan disease, isotretinoin monotherapy and
combination therapies of isotretinoin with
either ketotifen or clofazimine all produced
good results [12, 15].
These two cases illustrate this typical, almost
unmistakable, disease of solid facial edema
which produces a striking facies. This condition
does not stand alone—clinically closely com-
parable to the initial report of Connelly and
Winkelmann [6], quite similar reports of SFE as
a rare complication of rosacea (Morbihan dis-
ease) were published in 1957 [15]. Morbihan
disease also produces solid facial edema with
histopathologic features of granulomatous
rosacea that can occur at any stage of the disease
[15]. The pathogenesis of Morbihan disease also
remains unclear [15, 16], the two main
hypotheses being lymph vessel abnormalities or
the edema representing an inflammatory effect
[12, 15]. This peculiar edema is not reduced
when standing, nor does it show variation
during the day. Interestingly, a number of other
facial dermatoses can produce similar effects,
including dermatomyositis, angiedema, Melk-
ersson–Rosenthal and Heerfordt’s syndrome
[17–19].
We believe a common inflammatory pattern
may be underlying all these conditions. A
Fig. 2 Biopsy of case 1 revealing dermal edema and ﬁbrosis as well as mixed cellular inﬁltrate around the pilo-sebaceous unit
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number of mediators are directly involved in
induction of edema, including bradykinin,
interleukin 1 beta, histamine and others. These
are produced by cells both of the innate (mast
cells, granulocytes, monocytes/macrophages) as
well as of the adaptive immune system (T cells).
We have therefore undertaken comparative
studies that are currently ongoing. Once the
pathogenesis of persisting edema is better
understood, more targeted and effective thera-
pies might be within our reach.
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